Cancer Software
-
based in IRELAND
ONCOpatient is a digital solution to monitor cancer patients’ health from their homes. This empowers them to manage their condition more effectively with fewer hospital visits and, ultimately, increasing their chances of a good life quality and positive outcomes. ONCOpatient helps healthcare professionals in improving ...
-
based in USA
Lumin Bioinformatics is a dynamic analytic and visualization software that empowers cancer biologists to harness the power of computational science in a convenient and sophisticated tool. The power of Lumin is in the ability to explore and perform analysis on rich and unique datasets assembled from over 12,000 cancer patients, including ...
-
based in USA
Creates a heatmap assisting the pathologist in automatically finding the critical areas of the sample. Rapidly distinguishes between normal and cancerous tissue supporting the pathologist in the quick detection of tumor epithelium. Automatically scores the PD-L1 positive and negative cells of epithelial origin from whole slide images (WSI) ...
-
based in USA
Creates a heatmap assisting the pathologist in automatically finding the critical areas of the sample. Rapidly distinguishes between normal and cancerous tissue supporting the pathologist in the quick detection of tumor epithelium. Automatically scores the ER positive and negative cells of epithelial origin from either WSI or selected image ...
-
Manufactured by OTraces Inc.based in USA
and eventually breast cancer patient monitoring and screening, and access is now being offered to other companies through a unique cloud-based deployment program that could take higher predictive power to other companies and laboratories around the ...
-
based in USA
Creates a heatmap assisting the pathologist in automatically finding the critical areas of the sample. Rapidly distinguishes between normal and cancerous tissue supporting the pathologist in the quick detection of tumor epithelium. utomatically scores the Ki67 positive and negative cells of epithelial origin from either WSI or selected ...
-
based in USA
Creates a heatmap assisting the pathologist in automatically finding the critical areas of the sample. Rapidly distinguishes between normal and cancerous tissue supporting the pathologist in the quick detection of tumor epithelium. Automatically scores the PR positive and negative cells of epithelial origin from either WSI or selected image ...
-
based in USA
Cancer diagnosis with ultrasound requires great vision. Koios uses artificial intelligence and machine learning to provide clinical decision support (“DS”) for physicians and technologists when using ultrasound to detect and diagnose cancer. The result: Smart Ultrasound™ Research continues to prove that physician ...
-
based in USA
Hematological tumors represent the fourth most frequent cancer type in the developed world. In addition to the continuously evolving clinical guidelines2, harnessing of all the available information when investigating hematological disorders into meaningful insights can be outdated, inaccurate, costly, and time-consuming. This ultimately ...
-
based in USA
Hereditary causes account for ∼10% of cancer cases, and an estimated 20% of cancer patients have a family history of cancer. Identification of an individual with a suspected hereditable cancer can lead to additional examinations and help formulate the most appropriate prevention strategies. Evaluating the predisposition to ...
-
by Cortechs.aibased in USA
OnQ Prostate is FDA-cleared post-processing software that supports improved detection of clinically significant prostate cancer. Leveraging an advanced diffusion MRI technique called Restriction Spectrum Imaging, powered by AI, the software enables faster, more accurate PI-RADS ...
-
based in USA
NLP-based AI for automated cancer datasets and registry reporting. Inspirata’s E-Path suite of cancer registry automation solutions is powered by an oncology-specific Natural Language Processing (NLP) based artificial intelligence fine-tuned for cancer reporting. While complementing existing workflows, E-Path removes operator ...
-
by Arterys Inc.based in USA
Breast AI provides innovative solutions for breast cancer detection, measure breast density and assess personalized risk that offer clinically proven benefits to clinicians and patients, and are designed to optimize efficiency, enhance the patient experience, and improve outcomes. ...
-
based in USA
Rapidly distinguishes between normal and cancerous tissue supporting the pathologist in the quick detection of tumor areas. Automatically scores a quantitative Gleason grade score and grade group from WSI, saving the pathologist time. Provides visual feedback as it allows to view images in different magnifications, move in different ...
-
based in FRANCE
Moovcare® is a digital therapeutic that uses a simple weekly questionnaire to detect relapse or complication during follow-up of lung cancer patients. A Class I medical device, Moovcare has been proven in clinical trials to improve overall survival by 7.6 ...
-
based in USA
Provide streamlined care coordination through standardized orders and care pathways. Stratify patients into care populations and prioritize management of high-risk patients. Automatically assign tasks to the appropriate staff member (so patients receive the right care at the right ...
-
based in USA
Enable real-time oral adherence and symptom reporting while patients are on treatment. Receive proactive information on side effects and intervene quickly. Empower patients to stay on treatment with medication reminders and digital at-home care ...
-
by Lunit Inc.based in SOUTH KOREA
Lunit INSIGHT MMG is all about breast cancer. Accurately detects lesions suspicious of breast cancer in a mammogram. Developed using Lunit’s cutting-edge deep learning ...
-
Manufactured by Agilent Technologies, Inc.based in USA
Agilent SureCall software allows clinical researchers who use NGS panels for inherited diseases and cancer, to analyze, visualize, and contextualize NGS data using a single application. SureCall is a key component of Agilent's NGS Target Enrichment solution which includes SureDesign, Agilent's custom design tool and HaloPlex or SureSelect ...
-
based in USA
ELC1: LEPTOMENINGEAL CARCINOMATOSIS (LC). A devastating form of Cancer effecting 110,000 Patients/Yr. US, with a current life expectancy 2-7 months. Involvement by cancer of pia & arachnoid mater of the brain with the subarachnoid space in between. High incidence from breast, lung & ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you